Stock IART INTEGRA LIFESCIENCES HOLDINGS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Integra LifeSciences Holdings Corporation

Equities

IART

US4579852082

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
27.49 USD +3.85% Intraday chart for Integra LifeSciences Holdings Corporation +8.66% -36.88%
May. 07 Truist Cuts Price Target on Integra LifeSciences Holdings to $25 From $37, Keeps Hold Rating MT
May. 07 Wells Fargo Downgrades Integra LifeSciences Holdings to Equalweight From Overweight, Cuts Price Target to $25 From $45 MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 5,004 5,471 5,674 4,683 3,405 2,086 - -
Enterprise Value (EV) 1 6,153 6,555 6,707 5,670 4,605 3,378 3,529 3,385
P/E ratio 100 x 41.4 x 33.8 x 26 x 51.8 x 24.1 x 14.9 x 13.3 x
Yield - - - - - - - -
Capitalization / Revenue 3.3 x 3.99 x 3.68 x 3.01 x 2.21 x 1.24 x 1.18 x 1.13 x
EV / Revenue 4.05 x 4.78 x 4.35 x 3.64 x 2.99 x 2.02 x 1.99 x 1.83 x
EV / EBITDA 16.7 x 19.6 x 16.7 x 13.8 x 12.5 x 9.03 x 8.68 x 7.6 x
EV / FCF 38 x 39.7 x 25.4 x 25.5 x 63 x 24.4 x 15.5 x 15.2 x
FCF Yield 2.63% 2.52% 3.94% 3.92% 1.59% 4.09% 6.44% 6.56%
Price to Book 3.53 x 3.61 x 3.37 x 2.6 x 2.14 x 1.26 x 1.15 x 1.04 x
Nbr of stocks (in thousands) 85,866 84,273 84,700 83,518 78,176 78,800 - -
Reference price 2 58.28 64.92 66.99 56.07 43.55 27.49 27.49 27.49
Announcement Date 2/19/20 2/18/21 2/23/22 2/22/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,518 1,372 1,542 1,558 1,542 1,676 1,772 1,854
EBITDA 1 368.6 334.5 400.7 411.3 369.7 374.3 406.4 445.2
EBIT 1 324.4 240.4 314.1 366.6 329.1 331.7 360.1 385.5
Operating Margin 21.38% 17.52% 20.36% 23.53% 21.35% 19.79% 20.32% 20.79%
Earnings before Tax (EBT) 60.1 93.52 - - - - - -
Net income 1 50.2 133.9 169.1 180.6 67.74 95.31 157 208.5
Net margin 3.31% 9.76% 10.96% 11.59% 4.39% 5.69% 8.86% 11.25%
EPS 2 0.5800 1.570 1.980 2.160 0.8400 1.140 1.850 2.070
Free Cash Flow 1 161.9 164.9 264.4 222.1 73.09 138.2 227.1 222
FCF margin 10.67% 12.02% 17.14% 14.26% 4.74% 8.25% 12.82% 11.98%
FCF Conversion (EBITDA) 43.92% 49.31% 65.99% 54% 19.77% 36.94% 55.88% 49.86%
FCF Conversion (Net income) 322.5% 123.19% 156.38% 123.03% 107.9% 145.06% 144.67% 106.47%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/19/20 2/18/21 2/23/22 2/22/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 405.5 376.6 397.8 385.2 398 380.8 381.3 382.4 397 368.9 413.1 434.3 459.3 407.6 432.5
EBITDA 1 105.4 93.55 102.8 105.3 109.7 92.25 88.81 88.1 100.5 71.84 80.98 103.2 118.2 86.08 94.73
EBIT 1 93.89 83.96 91.38 93.72 98.82 81.53 65.74 95.2 80.58 61.89 70 92.72 107.2 76.35 83.85
Operating Margin 23.15% 22.29% 22.97% 24.33% 24.83% 21.41% 17.24% 24.89% 20.3% 16.78% 16.95% 21.35% 23.35% 18.73% 19.38%
Earnings before Tax (EBT) - - - - - - - - - - - - - - -
Net income 1 45.38 32.9 44.79 49.92 52.95 24.23 4.184 19.5 19.83 -3.281 17.74 35.14 45.7 22.68 31.1
Net margin 11.19% 8.74% 11.26% 12.96% 13.3% 6.36% 1.1% 5.1% 5% -0.89% 4.29% 8.09% 9.95% 5.57% 7.19%
EPS 2 0.5300 0.3900 0.5400 0.6000 0.6300 0.2900 0.0500 0.2400 0.2500 -0.0400 0.2000 0.4250 0.5550 0.3075 0.4133
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 2/23/22 4/27/22 7/27/22 10/26/22 2/22/23 4/26/23 7/26/23 10/25/23 2/28/24 5/6/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,149 1,084 1,033 987 1,200 1,292 1,443 1,299
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.118 x 3.242 x 2.578 x 2.399 x 3.246 x 3.453 x 3.55 x 2.918 x
Free Cash Flow 1 162 165 264 222 73.1 138 227 222
ROE (net income / shareholders' equity) 17% 14.2% 17% 16.1% 14.6% 13.7% 18.2% 22.2%
ROA (Net income/ Total Assets) 7.41% 6.03% 7.35% 7.32% 6.46% 6.26% 6.37% 6.78%
Assets 1 677.9 2,220 2,302 2,466 1,049 1,524 2,466 3,075
Book Value Per Share 2 16.50 18.00 19.90 21.60 20.30 21.90 23.90 26.50
Cash Flow per Share 2 2.680 2.390 3.650 3.170 - 1.880 2.590 -
Capex 1 69.5 38.9 48 42.3 66.9 66 64 63
Capex / Sales 4.58% 2.83% 3.11% 2.72% 4.34% 3.94% 3.61% 3.4%
Announcement Date 2/19/20 2/18/21 2/23/22 2/22/23 2/28/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Integra LifeSciences Holdings Corporation

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
27.49 USD
Average target price
33.8 USD
Spread / Average Target
+22.95%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
INTEGRA LIFESCIENCES HOLDINGS CORPORATION Stock Integra LifeSciences Holdings Corporation
-36.88% 2.09B
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.72% 182B
MEDTRONIC PLC Stock Medtronic plc
+3.96% 112B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-2.93% 68.58B
DEXCOM, INC. Stock DexCom, Inc.
+6.30% 51.58B
CENCORA, INC. Stock Cencora, Inc.
+8.02% 44.24B
HOYA CORPORATION Stock Hoya Corporation
+9.45% 43.65B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+26.18% 32.46B
TERUMO CORPORATION Stock Terumo Corporation
+20.94% 25.99B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+0.57% 25.61B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. IART Stock
  4. Financials Integra LifeSciences Holdings Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW